As of 2026-03-29, the Relative Valuation of Sangamo Therapeutics Inc (SGMO) is (6.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 USD, the upside of Sangamo Therapeutics Inc based on Relative Valuation is -2140.4%.
The range of the Relative Valuation is (6.09) - (6.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 25.1x | 22.0x |
| Forward P/E multiples | 20.0x - 22.9x | 21.0x |
| Fair Price | (6.09) - (6.98) | (6.55) |
| Upside | -1998.4% - -2275.8% | -2140.4% |
| Date | P/E |
| 2026-03-26 | -1.13 |
| 2026-03-25 | -1.15 |
| 2026-03-24 | -1.15 |
| 2026-03-23 | -1.10 |
| 2026-03-20 | -1.09 |
| 2026-03-19 | -1.12 |
| 2026-03-18 | -1.18 |
| 2026-03-17 | -1.25 |
| 2026-03-16 | -1.18 |
| 2026-03-13 | -1.24 |
| 2026-03-12 | -1.30 |
| 2026-03-11 | -1.34 |
| 2026-03-10 | -1.36 |
| 2026-03-09 | -1.35 |
| 2026-03-06 | -1.24 |
| 2026-03-05 | -1.24 |
| 2026-03-04 | -1.30 |
| 2026-03-03 | -1.29 |
| 2026-03-02 | -1.41 |
| 2026-02-27 | -1.42 |
| 2026-02-26 | -1.44 |
| 2026-02-25 | -1.54 |
| 2026-02-24 | -1.55 |
| 2026-02-23 | -1.28 |
| 2026-02-20 | -1.26 |
| 2026-02-19 | -1.25 |
| 2026-02-18 | -1.19 |
| 2026-02-17 | -1.21 |
| 2026-02-13 | -1.27 |
| 2026-02-12 | -1.24 |
| 2026-02-11 | -1.28 |
| 2026-02-10 | -1.28 |
| 2026-02-09 | -1.31 |
| 2026-02-06 | -1.31 |
| 2026-02-05 | -1.16 |
| 2026-02-04 | -1.18 |
| 2026-02-03 | -1.28 |
| 2026-02-02 | -1.86 |
| 2026-01-30 | -1.76 |
| 2026-01-29 | -1.68 |
| 2026-01-28 | -1.19 |
| 2026-01-27 | -1.24 |
| 2026-01-26 | -1.26 |
| 2026-01-23 | -1.24 |
| 2026-01-22 | -1.31 |
| 2026-01-21 | -1.25 |
| 2026-01-20 | -1.20 |
| 2026-01-16 | -1.32 |
| 2026-01-15 | -1.41 |
| 2026-01-14 | -1.42 |